---
title: "iBio 宣布 5000 万美元公开发行的定价"
description: "圣地亚哥，2025 年 8 月 19 日（GLOBE NEWSWIRE）-- iBio, Inc.（纳斯达克：IBIO），一家以人工智能驱动的精准抗体疗法创新公司，今天宣布了一项承销的公开发行（“发行”）的定价，包括（i）预先融资的认股权证，购买 71,540,000 股 iBio 普通股"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/253652806.md"
published_at: "2025-08-19T13:11:35.000Z"
---

# iBio 宣布 5000 万美元公开发行的定价

> 圣地亚哥，2025 年 8 月 19 日（GLOBE NEWSWIRE）-- iBio, Inc.（纳斯达克：IBIO），一家以人工智能驱动的精准抗体疗法创新公司，今天宣布了一项承销的公开发行（“发行”）的定价，包括（i）预先融资的认股权证，购买 71,540,000 股 iBio 普通股

SAN DIEGO, Aug. 19, 2025 ( GLOBE NEWSWIRE ) -- iBio, Inc. ( Nasdaq: IBIO ) , an AI-driven innovator of precision antibody therapies, today announced the pricing of an underwritten public offering ( the "offering" ) of ( i ) pre-funded warrants to purchase 71,540,000 shares of iBio's common stock ...

### Related Stocks

- [IBIO.US - iBio](https://longbridge.com/zh-CN/quote/IBIO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| iBio Announces Private Placement to Fund Pipeline Expansion | iBio, Inc. has announced a private placement to raise approximately $26 million by selling 1,408,481 common shares and p | [Link](https://longbridge.com/zh-CN/news/272329206.md) |
| iBio announces private placement financing to raise ~$26M | iBio (IBIO) has announced a private placement financing to raise approximately $26 million through a securities purchase | [Link](https://longbridge.com/zh-CN/news/272079227.md) |
| iBio Inc. reports Q2 research and development expenses of USD 4.28 million | iBio Inc. reported Q2 financial results with zero revenue and R&D expenses of $4.28 million. For the six months ending D | [Link](https://longbridge.com/zh-CN/news/275509977.md) |
| iBio Inc. Held Annual Shareholder Meeting | iBio Inc. held its Annual Meeting of Stockholders on November 20, 2025. Stockholders elected Dr. Martin Brenner and Dr.  | [Link](https://longbridge.com/zh-CN/news/266931236.md) |
| iBio Inc expected to post a loss of 10 cents a share - Earnings Preview | iBio Inc is expected to report a loss of 10 cents per share and a quarterly revenue of $25,000 for the period ending Sep | [Link](https://longbridge.com/zh-CN/news/264887883.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。